Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis

Bulletin of the World Health Organization

Volumn 77, Issue 8, 1999, Pages 667-674

  Boelaert, M ^a   Lynen, L ^a   Desjeux, P ^b   Van Der Stuyft, P ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COST; DISEASE CONTROL; HEALTH CARE; LEISHMANIASIS;

AGGLUTINATION TEST; ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; LABORATORY TEST; LEISHMANIASIS; PARASITE IDENTIFICATION;

COST EFFECTIVENESS; DISEASES; EVALUATION; EVALUATION INDEXES; EXAMINATIONS AND DIAGNOSES; LABORATORY EXAMINATIONS AND DIAGNOSES; LEISHMANIASIS; MATHEMATICAL MODEL; MODELS, THEORETICAL; PARASITIC DISEASES; QUANTITATIVE EVALUATION; RESEARCH METHODOLOGY; SUMMARY REPORT; TREATMENT;

AGGLUTINATION TESTS; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; HUMANS; LEISHMANIASIS, VISCERAL; SENSITIVITY AND SPECIFICITY;

EID: 0032877598     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Murray CJL, Lopez A. Global health statistics: a compendium of incidence, prevalence and mortality estimates for over 200 conditions. Boston, MA, Harvard School of Public Health on behalf of World Health Organization and World Bank, 1996 (Global Burden of Disease and Injury Series, vol. 2).
2. Mahmoud AAF, Warren KS. Algorithms in the diagnosis and management of exotic diseases. XXIV. Leishmaniasis. Journal of infectious diseases, 1977: 136, 160-163.
3. Griekspoor A, Sondorp E, Vos T. Cost-effectiveness analysis of humanitarian relief interventions: visceral leishmaniasis treatment in the Sudan. Health policy and planning, 1999: 14, 70-76.
4. Manual on visceral leishmaniasis control. Geneva, World Health Organization, 1996 (unpublished document WHO/Leish/96.40 available upon reguest from: Communicable Diseases, World Health Organization, 1211 Geneva 27, Switzerland).
5. Zijlstra EE et al. Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1992, 86: 505-507.
6. Kager PA, Rees PH. Splenic aspiration, review of the literature. Tropical and geographical medicine, 1983, 35: 111-124.
7. Kager PA et al. Splenic aspiration: experience in Kenya. Tropical and geographical medicine, 1983, 35: 125-131.
8. Thakur CP. A comparison of intercostal and abdominal routes of splenic aspiration and bone marrow aspiration in the diagnosis of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1997, 91: 668-670.
9. Kar K. Serodiagnosis of leishmaniasis. Critical reviews in microbiology, 1995, 21: 123-152.
10. El Safi SH, Evans DA. A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1989, 83: 334-337.
11. Boelaert M et al. Operational validation of the direct agglutination test (DAT) for diagnosis of visceral leishmaniasis. American journal of tropical medicine and hygiene, 1999, 60: 129-134.
12. Chowdhury MS et al. Applicability of direct agglutination test (DAT) at a rural health setting in Bangladesh and feasibility of local antigen production. Archives de l'Institut Pasteur de Tunis, 1993,70:333-344.
13. El Masum MA et al. Visceral leishmaniasis in Bangladesh: the value of DAT as a diagnostic tool. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1995, 89: 185-186.
14. El Harith A et al. A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1986, 80: 583-587.
15. El Harith A et al. Improvement of a direct agglutination test for field studies of visceral leishmaniasis. Journal of clinical microbiology, 1988, 26: 1321-1325.
16. Zijlstra EE et al. Direct agglutination test for diagnosis and sero-epidemiological survey of kala-azar in the Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1991, 85: 474-476.
17. Boelaert M et al. Latent class analysis permits unbiased estimates of the validity of DAT for the diagnosis of viscera leishmaniasis. Tropical medicine and international health, 1999, 4: 395-401.
18. Weinstein MC, Fineberg HV. Clinical decision analysis. Philadelphia, PA, Saunders, 1980.
19. Veeken H. Manual for the diagnosis and treatment of visceral leishmaniasis (kala-azar) under field conditions. Médecins sans Frontières, Amsterdam, 1999 (unpublished document).
20. Chulay JD, Spencer HC, Mugambi M. Electrocardiographic changes curing treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). American journal of tropical medicine and hygiene, 1985, 34: 702-709.
21. Thakur CP. Harmful effect of high stibogluconate treatment of kala-azar in India. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1986, 80: 672-673.
22. Marsden PD. Mucosal leishmaniasis ("espundia" Escomel, 1911). Transactions of the Royal Society of Tropical Medicine and Hygiene, 1986, 80: 859-876.
23. El Hassan AM et al. Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment Transactions of the Royal Society of Tropical Medicine and Hygiene, 1995, 89: 647-652.
24. Bryceson A et al. Visceral leishmaniasis unresponsive to antimonia drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1985, 79:705-714.
25. Reynolds JEF. Antiprotozoal agents. In: Martindale: the extra pharmacopoeia. London, Pharmaceutical Press, 1993: 526-527.
26. Boelaert M et al. Multi-centre evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis. Tropical medicine and international health, 1999, 4: 31-37.
27. Sundar S et al. Clinicoepidemiological study of drug resistance in Indian kala-azar. British medical journal, 1994, 308: 307.
28. Abdel Hameed AA, El Harith A, Abdel Rahim IM. Potential of a direct agglutination test (DAT) for detection of visceral leishmaniasis in a known endemic area in Sudan. Tropical medicine and parasitology, 1989, 40: 470-471.
29. de Beer P et al. A killing disease epidemic among displaced Sudanese population identified as visceral leishmaniasis. A merican journal of tropical medicine and hygiene, 1991, 44: 283-289.
30. El Harith A et al. Evaluation of cleaving agents other than trypsin in direct agglutination test for further improving diagnosis of visceral leishmaniasis. Journal of clinical microbiology, 1995, 33: 1984-1988.
31. Hailu A. Pre-and post-treatment antibody levels in visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1990, 84: 673-675.
32. Chowdhury MS et al. Prevalence of agglutinating anti-Leishmania antibodies in two multi-thousand Bengali communities. Parasitology research, 1993, 79: 444-450.
33. Schaefer KU et al. A prospective sero-epidemiological study of visceral leishmaniasis in Baringo District, Rift Valley Province, Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1995, 89: 471-475.
34. Okong'o Odera EA et al. Field application of an ELISA using redefined Leishmania antigens for the detection of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1993, 87: 423-424.